-0.000249221183800573 -0.000747663551401898 0.000623052959501522 -0.000623052959501522 -0.000872274143302096 -0.00411214953271026 -0.00186915887850457 -0.00186915887850457
Sign Up Today X
Thanks for submitting the form.
Stockreport

Gilead Surges To 2-Year High On Expectations For Speedy Coronavirus Drug [Investor's Business Daily]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Investors Business Daily
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Related news 4:20 PM ET Three Biogen employees tested positive for Covid-19, a new form of coronavirus, after attending a meeting of about 175 people... Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout? How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street? Travel Curbs Tighten; Fiscal Packages Multiply: Virus Update Alnylam Unveils Powerhouse Match-Up To Tackle Coronavirus Outbreak Coronavirus News: As Covid-19 Infects Stock Market, Economy And Business Face Test Emergency Measures Go Global As Cases Top 90,000: Virus Update Thermo Fisher To Buy Qiagen For $10 Billion In Lab Tie-Up How Gilead's Newest Takeover Deal Will Bolster Its Cancer Strategy GILD stock popped Friday after an analyst suggested Gilead Sciences ( GILD ) could unveil the test results of a coronavirus treatment later this month. Officials in China are testing Gilead's drug, remdesivir, in two groups of patients with Covid-19, a [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

Gilead Surges To 2-Year High On Expectations For Speedy Coronavirus Drug [Investor's Business Daily]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Investors Business Daily
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Related news 4:20 PM ET Three Biogen employees tested positive for Covid-19, a new form of coronavirus, after attending a meeting of about 175 people... Can Gilead Change Its Dim Fortunes On An Immuno-Oncology Buyout? How To Trade Stocks: Do You Know The Seven Most Important Words On Wall Street? Travel Curbs Tighten; Fiscal Packages Multiply: Virus Update Alnylam Unveils Powerhouse Match-Up To Tackle Coronavirus Outbreak Coronavirus News: As Covid-19 Infects Stock Market, Economy And Business Face Test Emergency Measures Go Global As Cases Top 90,000: Virus Update Thermo Fisher To Buy Qiagen For $10 Billion In Lab Tie-Up How Gilead's Newest Takeover Deal Will Bolster Its Cancer Strategy GILD stock popped Friday after an analyst suggested Gilead Sciences ( GILD ) could unveil the test results of a coronavirus treatment later this month. Officials in China are testing Gilead's drug, remdesivir, in two groups of patients with Covid-19, a [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS